Ipas
For Support Of Ipas' Regional Strategy In Francophone West Africa
-
Amount$1,000,000
-
Program
-
Date Awarded4/16/2020
-
Term24 Months
-
Type of SupportGeneral Support/Program
Strategies
Overview
This project will support implementation of Ipas’ relatively new program to address unsafe abortion in Francophone West Africa. Ipas’ strategy for the subregion seeks to train health care providers to provide abortion services safely and advocate for improvements in the policy environment for abortion availability. To improve the quality of abortion services available to women in Francophone countries, Ipas works in close partnership with ministries of health, regional health bodies like the West Africa Health Organization, and a diverse set of research and advocacy organizations. Strategically, this grant is aligned with the international reproductive health substrategy’s goal to reduce the incidence of unsafe abortion in Francophone West Africa, particularly in Ouagadougou Partnership member countries.
About the Grantee
Grantee Website
www.ipas.org
Address
P.O. Box 9990, Chapel Hill, NC, 27515, United States
Grants to this Grantee
for support of Ipas Africa Alliance
This grant will provide core support for Ipas Africa Alliance, a member of the Ipas Impact Network, whose mission is to advance reproductive justice globally. The alliance works with partners to secure equitable contraception and abortion care in East Africa and to pursue advocacy for sexual and reproductive health and rights across Africa. This grant is aligned with the Global Reproductive Equity strategy. (Strategy: Global Reproductive Equity)
for general operating support
Ipas works to advance sexual and reproductive health and rights by enhancing women’s and girls’ access to and use of safe abortion and contraception. Ipas represents the primary global vanguard organization in the safe abortion sector, using a multifaceted approach that includes legal reform, health system strengthening, and community education and engagement. Ipas produces global goods that benefit the sector broadly — including programmatic tools, global monitoring of opposition actors, and a robust research agenda. (Strategy: Global Reproductive Equity)
